NORWELL, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- On September 18, 2025, DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) issued a press release disclosing that it had received a notice on September 12, 2025, from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the “Bid Price Rule”), so this matter was an additional basis for delisting. The Company is clarifying that since it was ...

Core Viewpoint - DIH Holding US, Inc. has received a notice from Nasdaq regarding its failure to comply with the Bid Price Rule, which may lead to delisting from the stock market [2][3] Group 1: Compliance Issues - On September 12, 2025, DIH was notified that it failed to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A) after its Class A common stock closed below $1.00 per share for 30 consecutive business days [2] - The company was given a compliance period of 180 days, which ended on September 8, 2025, but did not meet the requirements by that date [2] - DIH has requested a hearing before the Nasdaq Hearing Panel to appeal the delisting notice and has also requested an extended stay of any further action pending the hearing [3] Group 2: Future Plans - At the hearing, the company plans to present its strategy to demonstrate compliance with all applicable listing criteria, including the MVLS Rule, the Bid Price Rule, and the Reports Rule [3] - The Panel has the authority to grant an extension of up to 180 days for compliance with the MVLS and Bid Price Rules, and 360 days for the Reports Rule [3] - The company is exploring all options to regain compliance, but there is no assurance that the Panel will grant the request for continued listing [3] Group 3: Company Overview - DIH aims to "Deliver Inspiration & Health" by providing advanced robotic devices for physical rehabilitation, targeting individuals with disabilities and functional impairments [4] - The company is a global provider of rehabilitation solutions, focusing on interactive devices that aid in clinical research and rehabilitation for patients with mobility and functional challenges [4] - DIH has emerged through the mergers of leading technology providers in a fragmented industry, positioning itself as a transformative player in rehabilitation solutions [4]

Company Overview - DIH Holding US, Inc. is a global provider of advanced robotic devices for rehabilitation, focusing on patients with walking impairments, reduced balance, and impaired arm and hand functions [1][4] - The company aims to improve the daily lives of individuals with disabilities through innovative rehabilitation technologies that combine robotics with visual stimulation [4] Appointment of Barrett Mooney - Dr. Barrett Mooney has been appointed to the Board of Directors, bringing extensive experience in scaling complex manufacturing and technology businesses [2][3] - His background includes leading major acquisitions and transitioning companies to public markets, as well as expertise in artificial intelligence and operational excellence [2][3] Strategic Vision - The CEO, Jason Chen, expressed enthusiasm for Dr. Mooney's appointment, highlighting his operational expertise and experience in the rehabilitation robotics market [3] - Dr. Mooney emphasized the potential of DIH's innovative approach to transform patient outcomes in the growing rehabilitation market [3] Board Composition - The Board of Directors now consists of seven members, including five independent members, reinforcing the company's commitment to strong governance [3]

DIH Receives Notice for Continued Deficiency and Delist Letter from the Nasdaq Stock Market DIH Intends to Request Hearing to Appeal in a Timely Manner NORWELL, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) received a notice on September 2, 2025, from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that it had failed to regain compliance for continued listing requirements of the Nasdaq Global Market. As previously d ...

Company Compliance Issues - DIH Holding US, Inc. received a notice from Nasdaq for non-compliance with Listing Rule 5250(c)(1) due to failure to file its Form 10-Q for the period ended June 30, 2025, and being delinquent in filing its Form 10-K for the year ended March 31, 2025 [1][2] - The company has until September 29, 2025, to submit a plan to regain compliance, and if accepted, may have up to 180 days, or until January 12, 2026, to file the delinquent reports [2] Company Operations - DIH is focused on delivering inspiration and health to improve the lives of individuals with disabilities through advanced robotic devices for physical rehabilitation [4] - The company aims to transform a fragmented industry by providing solutions that enable intensive rehabilitation and training for patients with walking impairments and other functional challenges [4]

Company Overview - DIH Holding US, Inc. is a global provider of advanced robotic devices for rehabilitation, focusing on patients with walking impairments, reduced balance, and impaired arm and hand functions [1][4] - The company aims to improve the daily lives of individuals with disabilities through intensive rehabilitation solutions [4] Leadership Appointment - Scott R. Burell has been appointed to the Board of Directors, bringing over two decades of experience in healthcare finance and a strong background in life sciences [2][3] - Burell's previous roles include Chief Financial Officer at AIVITA Biomedical and CombiMatrix Corporation, where he successfully led complex transactions and M&A activities [2] Strategic Vision - CEO Jason Chen expressed confidence in Burell's financial expertise and experience in the life sciences sector, which will enhance the company's growth strategy [3] - Burell highlighted the significant opportunities in the growing rehabilitation robotics market and his commitment to supporting the company's mission [3] Board Composition - The Board of Directors now consists of six members, including four independent members, reinforcing the company's commitment to strong governance practices [3]

Company Overview - DIH Holding US, Inc. aims to "Deliver Inspiration & Health" by providing devices and solutions for intensive rehabilitation, targeting individuals with disabilities and functional impairments [4] - The company is a global provider of advanced robotic devices for physical rehabilitation, focusing on interactive visual stimulation to aid clinical research and rehabilitation for patients with walking impairments and reduced balance [4] - DIH has emerged through the mergers of leading niche technology providers, positioning itself as a transformative solutions provider in a fragmented industry [4] Compliance and Reporting - On July 29, 2025, DIH received a notice from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) due to the failure to file its Annual Report on Form 10-K for the period ended March 31, 2025 [1] - The company has 60 calendar days from the notice date to file the Annual Report, with the option to submit a compliance plan if unable to meet the deadline [2] - If the compliance plan is accepted, DIH may be granted up to 180 additional days to regain compliance [2] - The company is actively working with auditors and advisors to file the Annual Report as soon as possible, and the notice does not have an immediate impact on the listing or trading of its securities [3]

Core Insights - DIH Holding US, Inc. has appointed Dennis Streppa to its Board of Directors and as Chair of the Audit Committee, enhancing its governance structure [1][3] - Dennis Streppa brings extensive experience in public and private healthcare, having driven M&A value and managed significant business operations [2][3] - The Board now consists of five members, including three independent members, reinforcing the company's commitment to strong governance [3] Company Overview - DIH is a global provider of advanced robotic devices aimed at rehabilitation, focusing on patients with walking impairments, reduced balance, and impaired arm and hand functions [1][4] - The company aims to "Deliver Inspiration & Health" by improving the lives of individuals with disabilities through innovative rehabilitation solutions [4] - DIH has emerged as a transformative provider in a fragmented industry, consolidating various niche technology providers to enhance rehabilitation services [4]

Company Overview - DIH Holding US, Inc. is a global provider of advanced robotic devices for rehabilitation, focusing on patients with walking impairments, reduced balance, and impaired arm and hand functions [1][5] - The company aims to improve the daily lives of millions with disabilities through intensive rehabilitation solutions [5] Appointment of Professor Nick Ward - Professor Nick Ward, M.D. has been appointed to the DIH Scientific Advisory Board, bringing expertise in upper limb neurorehabilitation [1][4] - His role will involve providing insights into clinical practices and supporting the development of new approaches for motor recovery after stroke [4] Scientific Advisory Board (SAB) Composition - The DIH SAB consists of leading scientists and clinicians with diverse expertise relevant to DIH's rehabilitation solutions [3] - With the addition of Professor Ward, the SAB now includes nine distinguished members, enhancing the company's commitment to evidence-based innovation [4]

Core Insights - DIH Holding US, Inc. has appointed Rehazentrum Valens as a Center of Excellence, emphasizing their commitment to enhancing rehabilitation through innovative technologies [1][5] - The partnership aims to improve patient outcomes and support recovery journeys by integrating advanced rehabilitation technologies [1][2] Company Overview - DIH is a global provider of advanced robotic devices for rehabilitation, focusing on patients with walking impairments and other functional disabilities [1][6] - The company aims to deliver inspiration and health by blending robotic and virtual reality technologies with clinical insights [6] Rehazentrum Valens Profile - Established in 1970, Rehazentrum Valens is a leading rehabilitation center in Switzerland, specializing in neurological, musculoskeletal, and internal medicine rehabilitation [3][7] - The center is recognized for its interdisciplinary collaboration and patient-centered care, aiming to restore independence and quality of life for patients [3][8] Rehabilitation Technologies - Rehazentrum Valens utilizes DIH's Total Solution, including devices like ErigoPro, LokomatPro, Andago, and C-Mill VR+, to enhance rehabilitation programs [4] - The Armeo product family is also employed for advanced arm and hand therapy, catering to a wide range of patient needs [4] Strategic Importance - The recognition of Rehazentrum Valens as a DIH Center of Excellence highlights its leadership in evidence-based rehabilitation and commitment to integrating advanced technologies into patient care [5] - This partnership is expected to shape the future of rehabilitation by combining clinical excellence with innovative solutions [5]